Showing results (551-560 of 684) with videos related to
Sort By:
Pageof 69
Cardiovascular Diabetology|September 16, 2023
Plasma metabolite profiles associated with the World Cancer Research Fund/American Institute for Cancer Research lifestyle score and future risk of cardiovascular disease and type 2 diabetesSantiago Rios, Jesús F García-Gavilán, Nancy Babio, et al.JACC. Clinical Electrophysiology|March 20, 2026
Device Infection Using Chlorhexidine Irrigation vs an Antibacterial Envelope: A Propensity Score-Matched AnalysisJorge Eduardo Marin, Carlos Tapias, David Santacruz-Pacheco, et al.Journal of the American Heart Association|September 19, 2025
Presence of Clonal Hematopoiesis and Cardiac Events After Allogeneic Stem Cell TransplantationCooper Quartermaine, Zach Braunstein, Adnan Shaaban, et al.Journal of Medicinal Chemistry|August 13, 2024
Pharmacophore Identification and Structure-Activity Relationship Analysis of a Series of Substituted Azaindoles as Inhibitors of Trypanosoma bruceiLori Ferrins, Rosario Diaz, Carlos Cordon-Obras, et al.Journal of Clinical Medicine|November 26, 2022
Serum Selenium and Incident Cardiovascular Disease in the PREvención con DIeta MEDiterránea (PREDIMED) Trial: Nested Case-Control StudyMario Gutiérrez-Bedmar, Fernando Gil, Pablo Olmedo, et al.The Journal of Nutrition|February 10, 2017
Increases in Plasma Tryptophan Are Inversely Associated with Incident Cardiovascular Disease in the Prevención con Dieta Mediterránea (PREDIMED) StudyEdward Yu, Miguel Ruiz-Canela, Marta Guasch-Ferré, et al.Journal of Physiology and Biochemistry|April 2, 2023
Plasma lipidome and risk of atrial fibrillation: results from the PREDIMED trialEstefania Toledo, Clemens Wittenbecher, Cristina Razquin, et al.Journal of Medicinal Chemistry|September 20, 2025
Optimization of Physicochemical Properties and ADME for 2,4-Substituted 1H-Pyrrolo[2,3b]pyridines Inhibitors of Trypanosome ProliferationKelly A Bachovchin, Rosario Díaz, Gloria Ceballos-Perez, et al.Metabolites|June 2, 2021
Glycolysis Metabolites and Risk of Atrial Fibrillation and Heart Failure in the PREDIMED TrialNerea Becerra-Tomás, Miguel Ruiz-Canela, Pablo Hernández-Alonso, et al.NPJ Precision Oncology|June 19, 2024
Methylation marks in blood DNA reveal breast cancer risk in patients fulfilling hereditary disease criteriaMiguel Ruiz-De La Cruz, Héctor Martínez-Gregorio, Clara Estela Díaz-Velásquez, et al.Pageof 69